Daniela Pavlicenco is a scientist driven by a passion for genetics, immunology, and nanomedicine, with a strong focus on translating research into clinical applications. Her current research centres on identifying cellular and molecular traits within endometrial cancer cell subpopulations that drive metastasis, targeting innovative treatments for cancer.
Daniela’s commitment to bridging groundbreaking research and healthcare has led her toward biotech entrepreneurship, where she seeks to translate scientific discoveries into real-world health solutions. With a forward-looking approach, she actively engages in the scientific community, seeking collaboration and continuous learning.
Daniela is motivated by a desire to positively impact patient outcomes and is eager to contribute to the advancement of personalised medicine